Hereditary Cancer Testing Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251340 | Category: Medical Care | Pages: 104 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development.  It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
This report aims to provide a comprehensive presentation of the global market for Hereditary Cancer Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Cancer Testing. This report contains market size and forecasts of Hereditary Cancer Testing in global, including the following market information:
Global Hereditary Cancer Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hereditary Cancer Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
RNA Testing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hereditary Cancer Testing include Ambry Genetics (Konica Minota), Asper Biogene, Natera, Caris Life Sciences, BioReference Laboratories (GeneDx), LabSolutions, Progenity，Inc, ARUP Laboratories and Myriad, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hereditary Cancer Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hereditary Cancer Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hereditary Cancer Testing Market Segment Percentages, by Type, 2022 (%)
    RNA Testing
    DNA Testing
Global Hereditary Cancer Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hereditary Cancer Testing Market Segment Percentages, by Application, 2022 (%)
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Respiratory/Lung Cancer
    Other Cancers
Global Hereditary Cancer Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hereditary Cancer Testing Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hereditary Cancer Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hereditary Cancer Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Ambry Genetics (Konica Minota)
    Asper Biogene
    Natera
    Caris Life Sciences
    BioReference Laboratories (GeneDx)
    LabSolutions
    Progenity，Inc
    ARUP Laboratories
    Myriad
    NeoGenomics
    Blueprint Genetics
    CellMax Life
    Fulgent Genetics
    Strand Life Sciences
    Myogenes
    LabCorp
    Quest Diagnostics
    Pathway Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hereditary Cancer Testing, market overview.
Chapter 2: Global Hereditary Cancer Testing market size in revenue.
Chapter 3: Detailed analysis of Hereditary Cancer Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hereditary Cancer Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Hereditary Cancer Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hereditary Cancer Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hereditary Cancer Testing Overall Market Size
    2.1 Global Hereditary Cancer Testing Market Size: 2022 VS 2029
    2.2 Global Hereditary Cancer Testing Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hereditary Cancer Testing Players in Global Market
    3.2 Top Global Hereditary Cancer Testing Companies Ranked by Revenue
    3.3 Global Hereditary Cancer Testing Revenue by Companies
    3.4 Top 3 and Top 5 Hereditary Cancer Testing Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Hereditary Cancer Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hereditary Cancer Testing Players in Global Market
        3.6.1 List of Global Tier 1 Hereditary Cancer Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hereditary Cancer Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hereditary Cancer Testing Market Size Markets, 2022 & 2029
        4.1.2 RNA Testing
        4.1.3 DNA Testing
    4.2 By Type - Global Hereditary Cancer Testing Revenue & Forecasts
        4.2.1 By Type - Global Hereditary Cancer Testing Revenue, 2018-2023
        4.2.2 By Type - Global Hereditary Cancer Testing Revenue, 2024-2029
        4.2.3 By Type - Global Hereditary Cancer Testing Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hereditary Cancer Testing Market Size, 2022 & 2029
        5.1.2 Breast Cancer
        5.1.3 Gastrointestinal Cancer
        5.1.4 Prostate Cancer
        5.1.5 Respiratory/Lung Cancer
        5.1.6 Other Cancers
    5.2 By Application - Global Hereditary Cancer Testing Revenue & Forecasts
        5.2.1 By Application - Global Hereditary Cancer Testing Revenue, 2018-2023
        5.2.2 By Application - Global Hereditary Cancer Testing Revenue, 2024-2029
        5.2.3 By Application - Global Hereditary Cancer Testing Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Hereditary Cancer Testing Market Size, 2022 & 2029
    6.2 By Region - Global Hereditary Cancer Testing Revenue & Forecasts
        6.2.1 By Region - Global Hereditary Cancer Testing Revenue, 2018-2023
        6.2.2 By Region - Global Hereditary Cancer Testing Revenue, 2024-2029
        6.2.3 By Region - Global Hereditary Cancer Testing Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Hereditary Cancer Testing Revenue, 2018-2029
        6.3.2 US Hereditary Cancer Testing Market Size, 2018-2029
        6.3.3 Canada Hereditary Cancer Testing Market Size, 2018-2029
        6.3.4 Mexico Hereditary Cancer Testing Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Hereditary Cancer Testing Revenue, 2018-2029
        6.4.2 Germany Hereditary Cancer Testing Market Size, 2018-2029
        6.4.3 France Hereditary Cancer Testing Market Size, 2018-2029
        6.4.4 U.K. Hereditary Cancer Testing Market Size, 2018-2029
        6.4.5 Italy Hereditary Cancer Testing Market Size, 2018-2029
        6.4.6 Russia Hereditary Cancer Testing Market Size, 2018-2029
        6.4.7 Nordic Countries Hereditary Cancer Testing Market Size, 2018-2029
        6.4.8 Benelux Hereditary Cancer Testing Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Hereditary Cancer Testing Revenue, 2018-2029
        6.5.2 China Hereditary Cancer Testing Market Size, 2018-2029
        6.5.3 Japan Hereditary Cancer Testing Market Size, 2018-2029
        6.5.4 South Korea Hereditary Cancer Testing Market Size, 2018-2029
        6.5.5 Southeast Asia Hereditary Cancer Testing Market Size, 2018-2029
        6.5.6 India Hereditary Cancer Testing Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Hereditary Cancer Testing Revenue, 2018-2029
        6.6.2 Brazil Hereditary Cancer Testing Market Size, 2018-2029
        6.6.3 Argentina Hereditary Cancer Testing Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hereditary Cancer Testing Revenue, 2018-2029
        6.7.2 Turkey Hereditary Cancer Testing Market Size, 2018-2029
        6.7.3 Israel Hereditary Cancer Testing Market Size, 2018-2029
        6.7.4 Saudi Arabia Hereditary Cancer Testing Market Size, 2018-2029
        6.7.5 UAE Hereditary Cancer Testing Market Size, 2018-2029
7 Hereditary Cancer Testing Companies Profiles
    7.1 Ambry Genetics (Konica Minota)
        7.1.1 Ambry Genetics (Konica Minota) Company Summary
        7.1.2 Ambry Genetics (Konica Minota) Business Overview
        7.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Major Product Offerings
        7.1.4 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.1.5 Ambry Genetics (Konica Minota) Key News & Latest Developments
    7.2 Asper Biogene
        7.2.1 Asper Biogene Company Summary
        7.2.2 Asper Biogene Business Overview
        7.2.3 Asper Biogene Hereditary Cancer Testing Major Product Offerings
        7.2.4 Asper Biogene Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.2.5 Asper Biogene Key News & Latest Developments
    7.3 Natera
        7.3.1 Natera Company Summary
        7.3.2 Natera Business Overview
        7.3.3 Natera Hereditary Cancer Testing Major Product Offerings
        7.3.4 Natera Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.3.5 Natera Key News & Latest Developments
    7.4 Caris Life Sciences
        7.4.1 Caris Life Sciences Company Summary
        7.4.2 Caris Life Sciences Business Overview
        7.4.3 Caris Life Sciences Hereditary Cancer Testing Major Product Offerings
        7.4.4 Caris Life Sciences Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.4.5 Caris Life Sciences Key News & Latest Developments
    7.5 BioReference Laboratories (GeneDx)
        7.5.1 BioReference Laboratories (GeneDx) Company Summary
        7.5.2 BioReference Laboratories (GeneDx) Business Overview
        7.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Major Product Offerings
        7.5.4 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.5.5 BioReference Laboratories (GeneDx) Key News & Latest Developments
    7.6 LabSolutions
        7.6.1 LabSolutions Company Summary
        7.6.2 LabSolutions Business Overview
        7.6.3 LabSolutions Hereditary Cancer Testing Major Product Offerings
        7.6.4 LabSolutions Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.6.5 LabSolutions Key News & Latest Developments
    7.7 Progenity，Inc
        7.7.1 Progenity，Inc Company Summary
        7.7.2 Progenity，Inc Business Overview
        7.7.3 Progenity，Inc Hereditary Cancer Testing Major Product Offerings
        7.7.4 Progenity，Inc Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.7.5 Progenity，Inc Key News & Latest Developments
    7.8 ARUP Laboratories
        7.8.1 ARUP Laboratories Company Summary
        7.8.2 ARUP Laboratories Business Overview
        7.8.3 ARUP Laboratories Hereditary Cancer Testing Major Product Offerings
        7.8.4 ARUP Laboratories Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.8.5 ARUP Laboratories Key News & Latest Developments
    7.9 Myriad
        7.9.1 Myriad Company Summary
        7.9.2 Myriad Business Overview
        7.9.3 Myriad Hereditary Cancer Testing Major Product Offerings
        7.9.4 Myriad Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.9.5 Myriad Key News & Latest Developments
    7.10 NeoGenomics
        7.10.1 NeoGenomics Company Summary
        7.10.2 NeoGenomics Business Overview
        7.10.3 NeoGenomics Hereditary Cancer Testing Major Product Offerings
        7.10.4 NeoGenomics Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.10.5 NeoGenomics Key News & Latest Developments
    7.11 Blueprint Genetics
        7.11.1 Blueprint Genetics Company Summary
        7.11.2 Blueprint Genetics Business Overview
        7.11.3 Blueprint Genetics Hereditary Cancer Testing Major Product Offerings
        7.11.4 Blueprint Genetics Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.11.5 Blueprint Genetics Key News & Latest Developments
    7.12 CellMax Life
        7.12.1 CellMax Life Company Summary
        7.12.2 CellMax Life Business Overview
        7.12.3 CellMax Life Hereditary Cancer Testing Major Product Offerings
        7.12.4 CellMax Life Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.12.5 CellMax Life Key News & Latest Developments
    7.13 Fulgent Genetics
        7.13.1 Fulgent Genetics Company Summary
        7.13.2 Fulgent Genetics Business Overview
        7.13.3 Fulgent Genetics Hereditary Cancer Testing Major Product Offerings
        7.13.4 Fulgent Genetics Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.13.5 Fulgent Genetics Key News & Latest Developments
    7.14 Strand Life Sciences
        7.14.1 Strand Life Sciences Company Summary
        7.14.2 Strand Life Sciences Business Overview
        7.14.3 Strand Life Sciences Hereditary Cancer Testing Major Product Offerings
        7.14.4 Strand Life Sciences Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.14.5 Strand Life Sciences Key News & Latest Developments
    7.15 Myogenes
        7.15.1 Myogenes Company Summary
        7.15.2 Myogenes Business Overview
        7.15.3 Myogenes Hereditary Cancer Testing Major Product Offerings
        7.15.4 Myogenes Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.15.5 Myogenes Key News & Latest Developments
    7.16 LabCorp
        7.16.1 LabCorp Company Summary
        7.16.2 LabCorp Business Overview
        7.16.3 LabCorp Hereditary Cancer Testing Major Product Offerings
        7.16.4 LabCorp Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.16.5 LabCorp Key News & Latest Developments
    7.17 Quest Diagnostics
        7.17.1 Quest Diagnostics Company Summary
        7.17.2 Quest Diagnostics Business Overview
        7.17.3 Quest Diagnostics Hereditary Cancer Testing Major Product Offerings
        7.17.4 Quest Diagnostics Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.17.5 Quest Diagnostics Key News & Latest Developments
    7.18 Pathway Genomics
        7.18.1 Pathway Genomics Company Summary
        7.18.2 Pathway Genomics Business Overview
        7.18.3 Pathway Genomics Hereditary Cancer Testing Major Product Offerings
        7.18.4 Pathway Genomics Hereditary Cancer Testing Revenue in Global Market (2018-2023)
        7.18.5 Pathway Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Hereditary Cancer Testing Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?